The research will be advanced through the integration of cryo-electron microscopy (EM), nuclear magnetic resonance (NMR) spectroscopy, and X-ray diffraction (XRD) which are believed to progress key medical discoveries relating to global health challenges such as HIV/AIDS and cancer.
The research program will be enabled with FEI’s Titan Krios transmission electron microscope (TEM) used for structural biology, and continued development of other technologies necessary to advance the scientific scope of the collaboration.
The ‘Living Lab for Structural Biology,’ which will be located on the NIH campus.
NMR and XRD techniques are believed to help determine the structures of molecular complexes and proteins that play a role in the causes of various diseases, such as AIDS, diabetes and cancer.
FEI president and CEO Don Kania said the deal with NIH would help in their strategy to provide complete microscopy solutions for life science research.
"Helping our customers obtain increased value from electron microscopy in conjunction with and complementary to XRD and NMR is a key element of that plan," Kania added.